Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 63.17B | 62.68B | 62.78B | 61.46B | 61.54B |
Gross Profit | 11.39B | 9.93B | 10.12B | 11.65B | 11.42B |
EBITDA | 3.40B | 3.17B | 3.08B | 4.45B | 3.73B |
Net Income | 537.00M | 120.00M | 318.00M | 740.00M | 2.01B |
Balance Sheet | |||||
Total Assets | 46.34B | 51.56B | 47.13B | 46.90B | 48.06B |
Cash, Cash Equivalents and Short-Term Investments | 4.60B | 3.71B | 2.57B | 2.76B | 7.00B |
Total Debt | 14.71B | 14.55B | 12.22B | 12.34B | 15.12B |
Total Liabilities | 29.92B | 35.91B | 33.93B | 34.44B | 37.18B |
Stockholders Equity | 16.30B | 15.54B | 13.19B | 12.45B | 10.88B |
Cash Flow | |||||
Free Cash Flow | 933.00M | -438.00M | -204.00M | -1.79B | -161.00M |
Operating Cash Flow | 3.77B | 1.62B | 2.78B | 2.18B | 2.00B |
Investing Cash Flow | -2.83B | -2.53B | -2.98B | -3.92B | -373.00M |
Financing Cash Flow | 24.00M | 1.81B | -116.00M | -2.78B | -4.08B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | €102.35B | 11.56 | 9.92% | 2.46% | 7.80% | 32.69% | |
73 Outperform | $275.38B | 9.05 | 8.87% | 2.55% | 3.10% | -14.40% | |
72 Outperform | $573.63B | 17.21 | 9.85% | 1.47% | 13.75% | 412.78% | |
71 Outperform | ¥268.02B | 13.92 | 8.47% | 2.88% | 6.35% | 13.11% | |
68 Neutral | ¥263.47B | 22.89 | 14.22% | 1.54% | 11.20% | 29.64% | |
67 Neutral | ¥13.73B | 25.62 | 3.34% | ― | 0.79% | 350.42% | |
64 Neutral | ¥117.23B | 20.79 | 1.53% | -13.34% | -45.53% |